[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.173.184. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
September 3, 2008

Clopidogrel Treatment and the MEND-CABG II Trial—Reply

JAMA. 2008;300(9):1021-1022. doi:10.1001/jama.300.9.1021-b

In Reply: We share the interest of Dr Oh and colleagues in the use of clopidogrel and its relationship to both hemorrhagic and ischemic outcomes in patients undergoing CABG surgery. As they point out, the risks and benefits of clopidogrel before and after CABG surgery are controversial and poorly understood.1 Current guidelines from the American College of Cardiology and American Heart Association recommend discontinuing clopidogrel several days before CABG surgery and restarting it postoperatively for up to a year in patients with recent acute coronary syndromes.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×